Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Veltmann

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Journal of Cardiovascular Electrophysiology|October 5, 2020
A novel screening tool to unmask potential interference between S-ICD and left ventricular assist deviceChristos Zormpas, Jörg Eiringhaus, Henrike A K Hillmann, et al.
Transplantation and Cellular Therapy|June 20, 2022
Increased Late Noncardiac Nonrelapse Mortality in Patients with Atrial Fibrillation Diagnosed During Their Hospital Stay for Allogeneic Stem Cell TransplantationCatherina Lueck, Victoria Panagiota, Elke Dammann, et al.
BMC Cardiovascular Disorders|September 14, 2017
One symptom, two arrhythmias: the rare and the even rarerFlorian Zauner, Jan-Thorben Sieweke, Stephan Hohmann, et al.
Clinical Cardiology|September 3, 2011
Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary preventionFlorian Streitner, Juergen Kuschyk, Claudia Dietrich, et al.
Plos One|April 18, 2023
Changes in eligibility for a subcutaneous cardioverter-defibrillator after implantation of a left ventricular assist device-A prospective analysisChristos Zormpas, Johanna Mueller-Leisse, Stephan Hohmann, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|July 3, 2020
Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist deviceChristos Zormpas, Jörg Eiringhaus, Henrike A K Hillmann, et al.
International Journal of Cardiology. Heart & Vasculature|June 9, 2022
Usage of the wearable cardioverter-defibrillator during pregnancyJ-Jacqueline Olic, Claudia Stöllberger, Christoph Schukro, et al.
Cytokine|July 17, 2009
Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical stormFlorian Streitner, Juergen Kuschyk, Christian Veltmann, et al.
Sensors (Basel, Switzerland)|March 10, 2022
Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II SubstudyJohanna Mueller-Leisse, Johanna Brunn, Christos Zormpas, et al.
Herzschrittmachertherapie & Elektrophysiologie|January 27, 2025
Determining the QRS axis: visual estimation is equal to calculationJohanna Mueller-Leisse, Giulia Syrbius, Henrike Aenne Katrin Hillmann, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Journal of Cardiovascular Electrophysiology|October 5, 2020
A novel screening tool to unmask potential interference between S-ICD and left ventricular assist deviceChristos Zormpas, Jörg Eiringhaus, Henrike A K Hillmann, et al.
Transplantation and Cellular Therapy|June 20, 2022
Increased Late Noncardiac Nonrelapse Mortality in Patients with Atrial Fibrillation Diagnosed During Their Hospital Stay for Allogeneic Stem Cell TransplantationCatherina Lueck, Victoria Panagiota, Elke Dammann, et al.
BMC Cardiovascular Disorders|September 14, 2017
One symptom, two arrhythmias: the rare and the even rarerFlorian Zauner, Jan-Thorben Sieweke, Stephan Hohmann, et al.
Clinical Cardiology|September 3, 2011
Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary preventionFlorian Streitner, Juergen Kuschyk, Claudia Dietrich, et al.
Plos One|April 18, 2023
Changes in eligibility for a subcutaneous cardioverter-defibrillator after implantation of a left ventricular assist device-A prospective analysisChristos Zormpas, Johanna Mueller-Leisse, Stephan Hohmann, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|July 3, 2020
Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist deviceChristos Zormpas, Jörg Eiringhaus, Henrike A K Hillmann, et al.
International Journal of Cardiology. Heart & Vasculature|June 9, 2022
Usage of the wearable cardioverter-defibrillator during pregnancyJ-Jacqueline Olic, Claudia Stöllberger, Christoph Schukro, et al.
Cytokine|July 17, 2009
Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical stormFlorian Streitner, Juergen Kuschyk, Christian Veltmann, et al.
Sensors (Basel, Switzerland)|March 10, 2022
Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II SubstudyJohanna Mueller-Leisse, Johanna Brunn, Christos Zormpas, et al.
Herzschrittmachertherapie & Elektrophysiologie|January 27, 2025
Determining the QRS axis: visual estimation is equal to calculationJohanna Mueller-Leisse, Giulia Syrbius, Henrike Aenne Katrin Hillmann, et al.
Pageof 15